B-FREE Chronic Babesiosis Study

NCT06656351 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Babesiosis

Interventions

DRUG: Tafenoquine 100mg

Sponsor

60 Degrees Pharmaceuticals LLC